CoChat

The DOI matches its Crossref record; 25 of the 27 references it cites were found in a registry or an index.

Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa

Abstract

OBJECTIVE: To determine the burden and impact of immune reconstitution disease (IRD) associated with tuberculosis (TB) among patients initiating antiretroviral treatment (ART) in sub-Saharan Africa. DESIGN: Retrospective analysis of a study cohort enrolled over 3 years within a community-based ART service in South Africa. METHODS: Patients receiving treatment for TB at the time ART was initiated (n = 160) were studied. Cases of TB-associated IRD during the first 4 months of ART were ascertained. RESULTS: The median baseline CD4 cell count was 68 cells/microl [interquartile range (IQR), 29-133 cells/microl) and ART was initiated after a median of 105 days (IQR, 61-164 days) from TB diagnosis. Although IRD was diagnosed in just 12% (n = 19) of patients overall, IRD developed in 32% (n = 12) of those who started ART within 2 months of TB diagnosis. Pulmonary involvement was observed in 84% (n = 16) and intra-abdominal manifestations were also common (37%). Overall, 4% (n = 7) of the cohort required secondary level health-care for IRD and two (1%) patients died. In multivariate analysis, risk of IRD was strongly associated with early ART initiation and low baseline CD4 cell count. Of patients with CD4 counts < 50 cells/microl, the proportions who developed IRD following initiation of ART within 0-30, 31-60, 61-90, 91-120 and > 120 days of TB diagnosis were 100%, 33%, 14%, 7% and 0%, respectively. CONCLUSIONS: The risk of TB-associated IRD in this setting is very high for those with low baseline CD4 cell counts initiating ART early in the course of antituberculosis treatment. However, most cases were self-limiting; overall secondary health-care utilization and mortality risk from IRD were low.

Overview

Integrity signals

Registry

Crossref · 10.1097/qad.0b013e328011efac

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 25 references

Cited by

See all 346

Metadata

Authors
Lawn, S. D., Myer, L., Bekker, L.-G., & Wood, R.
Affiliations
University of Cape Town (ZA)
Corresponding author
Lawn, Stephen D
Venue
AIDS
Published
2007-01-30
Volume
21
Issue
3
Pages
335-341
ISSN
0269-9370 (ISSN-L)
OpenAlex
W2020198464
Cited by
343
References
27
Citations by year
2026: 1 · 2025: 3 · 2024: 4 · 2023: 3 · 2022: 1 · 2021: 8 · 2020: 4 · 2019: 7 · 2018: 9 · 2017: 10 · 2016: 8 · 2015: 12 · 2014: 16 · 2013: 31 · 2012: 25
FWCI
51.58
Type
journal article
Language
en
Open access
closed
Locations
  • AIDS (publishedVersion)
  • PubMed (publishedVersion)
  • LSHTM Research Online (London School of Hygiene and Tropical Medicine) (submittedVersion)
Funders
  • Wellcome Trust (074641)
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • National Institute of Allergy and Infectious Diseases (1U19 AI53217-01, AI 058736-01A1, U19AI053217, R01AI058736)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
  • Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
Keywords
tuberculosis, antiretroviral therapy, CD4 count, early ART initiation, risk factors, pulmonary tuberculosis, South Africa
MeSH terms
Adult, Antitubercular Agents, Developing Countries, Epidemiologic Methods, Female, Humans, Immune System Diseases, Inflammation, Male, South Africa, Tuberculosis, HIV Infections, AIDS-Related Opportunistic Infections, CD4 Lymphocyte Count, Anti-HIV Agents, Antiretroviral Therapy, Highly Active

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa. https://app.cochat.ai/papers/10.1097/qad.0b013e328011efac
The paper
Lawn, S. D., Myer, L., Bekker, L.-G., & Wood, R. (2007). Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa. AIDS. https://doi.org/10.1097/qad.0b013e328011efac

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.